Representative before the EPO

Employment test 51 - 200 employees
Company dna mathys and squire llp
no operation time available
Headquarter in London and 5 offices
active in Legal Services and Matchmaking and Trading

David James Miller has worked on the following 89 EPO patent applications which have been published in the last five years:

EP11749612

CHIMERIC IL-1 RECEPTOR TYPE I AGONISTS AND ANTAGONISTS

IPC classification:
A61P 19/02, C07K 14/545
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12702092

MATERIALS AND METHOD FOR DETECTING CYTOMEGALOVIRUS (CMV)

IPC classification:
C12Q 1/68, C12Q 1/70
Applicant:
Abbott Molecular Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12744843

IMMUNOGENIC COMPOSITION COMPRISING ALPHA-HEMOLYSIN OLIGOPEPTIDES

IPC classification:
A61K 38/00, A61K 39/02, C07H 21/04, C07K 5/00, C12N 15/00
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12723781

METHODS OF PREVENTING AND REMOVING TRISULFIDE BONDS

IPC classification:
C07K 1/113, C12N 5/00
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP11822565

SYSTEMIC, ALLOGENIC STEM CELL THERAPIES FOR TREATMENT OF DISEASES IN ANIMALS

IPC classification:
A61K 35/28, C12N 5/07, C12N 5/10
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12817042

ASSAYS TO MONITOR BLEEDING DISORDERS

IPC classification:
A61K 38/36, C07K 14/745, G01N 33/48
Applicant:
BIOGEN IDEC HEMOPHILIA INC.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12825669

NOVEL KIF5B-RET FUSION MOLECULES AND USES THEREOF

IPC classification:
C07K 14/82
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12714911

BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO IFNBETA AND USES THEREOF

IPC classification:
G01N 33/68
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12815922

MATERIALS AND METHODS FOR DIAGNOSIS, PROGNOSIS AND ASSESSMENT OF THERAPEUTIC/PROPHYLACTIC TREATMENT OF PROSTATE CANCER

IPC classification:
C12Q 1/68
Applicant:
Abbott Molecular Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
PATENT GRANTED
EP14169178

Methods of treatment using anti-ERBB antibody-maytansinoid conjugates

IPC classification:
A61K 47/48
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13735995

METHODS OF REDUCING IMMUNOGENICITY AGAINST FACTOR VIII IN INDIVIDUALS UNDERGOING FACTOR VIII THERAPY

IPC classification:
C12P 21/04
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14174866

Treatment for multiple sclerosis

IPC classification:
A61K 39/395, A61P 25/28, C07K 16/28
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12818630

METHODS AND APPARATUSES HARVESTING, MODIFYING AND REIMPLANTATION OF DERMAL MICRO -ORGANS

IPC classification:
A61B 17/322, A61K 35/36
Agent:
David James Miller, Mathys & Squire LLP
Status:
APPLICATION WITHDRAWN
EP12846452

USE OF AN ANTI-ALPHA-SYNUCLEIN ANTIBODY TO DIAGNOSE AN ELEVATED LEVEL OF ALPHA-SYNUCLEIN IN THE BRAIN

IPC classification:
A61K 39/395, G01N 33/53
Agent:
David James Miller, Mathys & Squire LLP
Agent:
Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP12868427

FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME

IPC classification:
A61K 38/37, C07K 14/755
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13749382

RECOMBINANT FACTOR VIII PROTEINS

IPC classification:
A61K 35/14, A61K 38/37
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13735649

CHIMERIC FACTOR VIII POLYPEPTIDES AND USES THEREOF

IPC classification:
A61K 38/37
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12180713

Adaptation of pitman moore strain of rabies virus to primary chick embryo fibroblast cell cultures

IPC classification:
A61K 39/205, C12N 5/07
Agent:
David James Miller, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13765090

JCV NEUTRALIZING ANTIBODIES

IPC classification:
C07K 14/24
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13768062

DELIVERY DEVICE AND COMPONENTS THEREOF

IPC classification:
A61M 5/00, A61M 5/315
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14178388

VLA-1 antagonist for use in treating stroke

IPC classification:
A61K 38/19, A61K 39/395, A61P 9/10
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13723287

COGNITIVE COMPOSITE PARAMETERS AND USES THEREOF FOR EVALUATING MULTIPLE SCLEROSIS

IPC classification:
A61B 5/16, G06F 19/00
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14190758

Antibodies to troponin I and methods of use therof

IPC classification:
C07K 14/47, C07K 16/18
Applicant:
Abbott Laboratories
Agent:
David James Miller, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13799785

PROCOAGULANT COMPOUNDS

IPC classification:
A61K 38/02, A61K 38/36, A61P 7/02
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13742451

PRODUCTION OF INFECTIOUS INFLUENZA VIRUSES

IPC classification:
C12N 7/00, C12N 7/02, C12N 15/85
Applicant:
Sanofi Pasteur SA
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13751009

DISEASE PROGRESSION PARAMETERS AND USES THEREOF FOR EVALUATING MULTIPLE SCLEROSIS

IPC classification:
A61B 5/00, G06F 19/00
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP11843556

STABLE PRESERVED COMPOSITIONS OF INTERFERON-BETA

IPC classification:
C12P 21/04
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11793578

ENRICHMENT AND CONCENTRATION OF SELECT PRODUCT ISOFORMS BY OVERLOADED BIND AND ELUTE CHROMATOGRAPHY

IPC classification:
B01D 15/42
Applicant:
Biogen Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13842864

METHODS OF USING FIX POLYPEPTIDES

IPC classification:
A61K 38/36, A61K 39/395, A61K 47/48, A61P 7/04
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP15160028

NOGO receptor binding protein

IPC classification:
A61K 38/00, A61K 38/17, A61K 39/395, A61K 48/00, C07K 14/47, C07K 14/705, C07K 16/18, C07K 16/28, C12N 15/12, C12N 15/62, C12N 15/63, G01N 33/50, G01N 33/68
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15160629

SPECIFIC BINDING PROTEINS AND USES THEREOF

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/30, G01N 33/50, G01N 33/574
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP13852306

METHODS OF USING FVIII POLYPEPTIDE

IPC classification:
A61K 39/395
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13814340

ANTI-BLOOD DENDRITIC CELL ANTIGEN 2 ANTIBODIES AND USES THEREOF

IPC classification:
C07K 16/28
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP14735224

SYSTEM AND METHOD FOR OUTCOME TRACKING AND ANALYSIS

IPC classification:
G06Q 50/24
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14738023

METHODS FOR IMPROVED PRODUCTION AND RECOVERY OF RECOMBINANT PROTEINS FROM EUKARYOTIC CELL CULTURES

IPC classification:
C12N 5/00, C12N 5/07, C12P 21/04
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
APPLICATION WITHDRAWN
EP15167892

APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

IPC classification:
A61K 31/437, A61K 31/496, C07D 471/04, C07D 491/052, C07D 519/00
Applicant:
AbbVie Bahamas Limited
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP14737761

MEDIUM SUPPLEMENTS FOR IMPROVED PROCESS PERFORMANCE

IPC classification:
C12N 5/00
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
APPLICATION WITHDRAWN
EP14745595

ASSAY FOR DETECTION OF JC VIRUS DNA

IPC classification:
C07H 21/00, C07H 21/04, C12Q 1/70
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14702616

METHOD FOR THE SELECTION OF ANTIBODIES AGAINST BCMA

IPC classification:
A61P 31/00, C07K 16/28
Agent:
David James Miller, Mathys & Squire LLP
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
EXAMINATION IN PROGRESS
EP14705304

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA

IPC classification:
A61P 31/00, C07K 16/28
Agent:
David James Miller, Mathys & Squire LLP
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
EXAMINATION IN PROGRESS
EP14751254

OPTIMIZED FACTOR VIII GENE

IPC classification:
C07K 14/755
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14765295

ONE-STEP PROCEDURE FOR THE PURIFICATION OF NUCLEIC ACIDS

IPC classification:
B01D 57/02, C07H 1/06, C12N 15/10, C12Q 1/68, G01N 27/447
Applicant:
Abbott Molecular Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14765076

COMPOSITIONS AND METHODS FOR NUCLEIC ACID EXTRACTION

IPC classification:
C12P 19/34
Applicant:
Abbott Molecular Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14764659

FACTOR IX POLYPEPTIDE FORMULATIONS

IPC classification:
A61K 38/48, A61K 39/00, C07K 16/00, C12N 9/96
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP13785756

PURIFICATION OF PROTEINS USING HYDROPHOBIC INTERACTION CHROMATOGRAPHY

IPC classification:
A61K 39/395, C07K 1/16, C07K 1/18, C07K 1/20, C07K 1/22, C07K 1/34, C07K 1/36, C07K 16/24
Applicant:
AbbVie Inc
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
APPLICATION WITHDRAWN
EP14765488

HYDROPHOBIC INTERACTION PROTEIN CHROMATOGRAPHY UNDER NO-SALT CONDITIONS

IPC classification:
C07K 1/20, C07K 16/00
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14715500

LOW ACIDIC SPECIES COMPOSITIONS AND METHODS FOR PRODUCING THE SAME USING DISPLACEMENT CHROMATOGRAPHY

IPC classification:
C07K 1/16, C07K 1/20, C07K 16/06, C07K 16/28
Applicant:
AbbVie Inc
Agent:
David James Miller, Mathys & Squire LLP
Status:
APPLICATION WITHDRAWN
EP14722865

ANTIBODY DRUG CONJUGATE (ADC) PURIFICATION

IPC classification:
A61K 47/48, A61P 35/00
Applicant:
AbbVie Inc
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14768286

DEVICE, SYSTEM, METHODS, AND COMPUTER READABLE MEDIA FOR MANAGING ACUTE AND CHRONIC PAIN

IPC classification:
A61N 1/32
Applicant:
The University of North Carolina at Chapel Hill - The Office of Technology Development and Economic Development
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14769555

DETECTION OF BISULFITE CONVERTED NUCLEOTIDE SEQUENCES

IPC classification:
C07H 21/04, C12Q 1/68
Applicant:
Abbott Molecular Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14725274

METHODS FOR PROMOTING WOUND HEALING AND HAIR GROWTH

IPC classification:
A61K 38/18, A61P 17/02, A61P 17/14, C07K 14/475
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14760955

DEVICES, SYSTEMS, AND METHODS FOR ACOUSTICALLY -ENHANCED MAGNETOPHORESIS

IPC classification:
B01D 35/06
Applicant:
Duke University - Office of Licensing & Ventures
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14779286

METHODS, COMPOSITIONS, AND KITS FOR DETECTING PROTEASE ACTIVITY IN COMPLEX SAMPLES

IPC classification:
A23K 20/168
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14765091

USE OF RAMAN SPECTROSCOPY TO MONITOR CULTURE MEDIUM

IPC classification:
G01J 3/44, G01N 21/65
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14795352

ANALYSIS OF GENETIC VARIANTS

IPC classification:
G06F 7/60, G06F 19/18, G06F 19/22
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15179545

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/46
Agent:
David James Miller, Mathys & Squire LLP
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
PATENT GRANTED
EP14803454

METHODS OF EVALUATING CELL CULTURE ADDITIVES

IPC classification:
A61K 31/765
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP15183033

A METHOD FOR THE HIGH LEVEL EXPRESSION OF THE ACTIVE LYMPHOTOXIN-BETA RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION

IPC classification:
A61K 38/00, C07K 19/00, C12N 1/19, C12N 1/21, C12N 5/10
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14818050

THROMBIN CLEAVABLE LINKER

IPC classification:
A61K 38/37
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14817900

THROMBIN CLEAVABLE LINKER WITH XTEN AND ITS USES THEREOF

IPC classification:
A61K 38/37
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14820267

COMPOSITIONS AND METHODS FOR TREATMENT OF STROKE

IPC classification:
C07K 16/28
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14835927

RECOMBINANT FACTOR VIII PROTEINS

IPC classification:
A61K 35/14, A61K 38/36, A61K 38/37, C07K 1/00, C07K 14/745, C07K 14/755
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14761736

CONTROL OF PROTEIN GLYCOSYLATION BY CULTURE MEDIUM SUPPLEMENTATION AND CELL CULTURE PROCESS PARAMETERS

IPC classification:
C12N 5/00
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14840445

CELL-SEEDED COMPOSITIONS AND METHODS USEFUL FOR TREATING BONE REGIONS

IPC classification:
A61K 35/12, A61K 35/32, A61P 19/00
Applicant:
Muffin Inc
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14839440

PRODUCTS COMPRISING AN EXTRACELLULAR MATRIX TISSUE MATERIAL AND OSTEOGENIC PROTEIN

IPC classification:
A61K 35/12, A61K 35/32, A61P 19/00
Applicant:
Muffin Inc
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14766617

TREATMENT METHODS FOR RHEUMATOID ARTHRITIS

IPC classification:
G01N 33/564
Agent:
David James Miller, Mathys & Squire LLP
Status:
APPLICATION WITHDRAWN
EP14842369

COMPOSITIONS AND METHODS FOR INCREASING MESENCHYMAL STROMAL CELL MIGRATION TO TUMORS

IPC classification:
G01N 33/574
Agent:
David James Miller, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12745253

S1P MODULATING AGENTS

IPC classification:
A61K 31/55, A61P 25/00, C07D 211/34, C07D 211/60, C07D 211/62, C07D 401/06, C07D 405/12
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
PATENT GRANTED
EP14805362

MICRO-ORGANS PROVIDING SUSTAINED DELIVERY OF A THERAPEUTIC POLYPEPTIDE AND METHODS OF USE THEREOF

IPC classification:
A61B 17/322, A61K 35/36
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14859449

PROCOAGULANT FUSION COMPOUND

IPC classification:
A61K 38/36
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14867154

POPULATION PHARMACOKINETICS TOOLS AND USES THEREOF

IPC classification:
A61K 38/37
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14827357

USE OF PERFUSION SEED CULTURES TO IMPROVE BIOPHARMACEUTICAL FED-BATCH PRODUCTION CAPACITY AND PRODUCT QUALITY

IPC classification:
C12M 1/34
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP15735473

FACTOR VIII CHIMERIC PROTEINS AND USES THEREOF

IPC classification:
A61K 38/36
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15710294

USE OF CATION-EXCHANGE CHROMATOGRAPHY IN THE FLOW-THROUGH MODE TO ENRICH POST-TRANSLATIONAL MODIFICATIONS

IPC classification:
C07K 1/18, C07K 14/745, C07K 14/755, C07K 16/00
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP16167345

IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS

IPC classification:
A61K 47/48, C07K 14/475, C07K 14/505, C07K 14/555, C07K 14/56, C07K 14/565, C07K 14/745, C07K 16/00, C12N 9/64, C12N 9/96
Agent:
David James Miller, Mathys & Squire LLP
Status:
Request for examination was made
EP15754919

METHOD OF ASSESSING RISK OF PML

IPC classification:
C12Q 1/68, G01N 33/53
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15716252

METHODS FOR OVERCOMING GLUTAMINE DEPRIVATION DURING MAMMALIAN CELL CULTURE

IPC classification:
C12N 5/00
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15769411

LYOPHILIZED FACTOR IX FORMULATIONS

IPC classification:
F26B 5/06
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15774029

METHODS OF USING PIGMENT EPITHELIUM DERIVED FACTOR (PEDF) FOR THE TREATMENT AND PREVENTION OF AGENT-INDUCED GONADAL OR UTERINE TOXICITY

IPC classification:
A61K 31/138, A61K 38/18, A61P 15/08
Applicant:
Ramot at Tel-Aviv University Ltd.
Applicant:
Mor Research Applications Ltd.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15718003

ANTI-EGFR ANTIBODIES AND ANTIBODY DRUG CONJUGATES

IPC classification:
A61K 39/00, A61P 35/00, C07K 14/00, C07K 16/28, A61K 47/50
Applicant:
AbbVie Inc
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15780065

MEDIUM USED FOR BLOOD SAMPLE COLLECTION AND TRANSPORT

IPC classification:
G01N 1/28
Applicant:
Abbott Molecular Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15724464

BIOMARKERS PREDICTIVE OF LUPUS PROGRESSION AND USES THEREOF

IPC classification:
G01N 33/50, G01N 33/53, G01N 33/567, G01N 33/68
Applicant:
Johns Hopkins University
Applicant:
University of Maryland, Baltimore - Office of Research and Development
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP16183267

S1P MODULATING AGENTS

IPC classification:
A61K 31/55, A61P 25/00, C07D 211/34, C07D 211/60, C07D 211/62, C07D 401/06, C07D 405/12
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
APPLICATION PUBLISHED
EP15735743

USE OF AMINOGLYCOSIDE ANALOGS IN THE TREATMENT OF RETT SYNDROME

IPC classification:
A61K 31/7036, A61P 25/00, A61P 43/00
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15814881

OPTIMIZED FACTOR IX GENE

IPC classification:
A61K 31/7088, C07H 21/00
Applicant:
Biogen MA Inc.
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15763443

PEGYLATION METHOD

IPC classification:
C07K 14/435, C07K 14/555, C07K 14/56, C07K 14/565
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP16200363

PROTEIN FORMULATIONS AND METHODS OF MAKING SAME

IPC classification:
A61K 9/08, A61K 9/19, A61K 38/21, A61K 38/46, A61K 38/48, A61K 38/50, A61K 39/395
Agent:
David James Miller, Mathys & Squire LLP
Status:
The application has been published
EP15833420

SYSTEM AND METHOD FOR MANAGING GENOMIC INFORMATION

IPC classification:
G06F 19/18, G06F 19/26
Agent:
David James Miller, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15832334

METHODS OF TREATING CERVICAL CANCER

IPC classification:
A61K 38/03, A61K 38/06, A61P 35/00, C07K 19/00
Agent:
David James Miller, Mathys & Squire LLP
Status:
Request for examination was made

Please Sign in to use this feature